Democrats’ victories in the midterm elections have renewed expectations that Congress could make progress on federal cannabis reform, with the party preparing to take control of both chambers.
The Democratic-led House has previously approved federal legalization proposals twice, with the most recent vote taking place in 2022. Efforts in the Senate, however, have faced greater resistance. Under Senate rules, most legislation requires 60 votes to overcome a filibuster, making it difficult to advance even measures with support from members of both parties, including proposals to improve banking access for marijuana companies.
The debate has also changed since Democrats last held congressional majorities. More states have adopted marijuana legalization policies, while the Trump administration has begun pursuing a narrower change to marijuana classification under the CSA.
Advocates are now urging the incoming Senate majority leader and House speaker to consider broader reform rather than rely solely on administrative changes. Both lawmakers have previously backed legislation to remove marijuana from the CSA. Their proposals have included the 2019 Marijuana Freedom and Opportunity Act and subsequent efforts to establish a regulated national cannabis market.
Democrats could secure up to 56 Senate seats, with 54 already confirmed. Two contests remain unresolved and available results suggest they could be won by Democrats. Passing comprehensive reform would therefore require cooperation from several Republican senators.
NORML’s Morgan Fox said roughly 66 percent of U.S. adults support ending prohibition. He urged Democratic leaders to respond to public opinion by pursuing legislation with bipartisan backing.
Fox also cautioned that federal rescheduling remains incomplete. Although medical cannabis has been moved to Schedule 3, broader changes covering recreational cannabis remain uncertain because of ongoing proceedings involving the DEA.
Drug Policy Alliance representative Cat Packer similarly argued that rescheduling alone would not address the consequences of federal criminalization. She called for legislation protecting individuals, improving public health safeguards, and creating a regulatory framework covering marijuana and hemp.
Meanwhile, National Cannabis Industry Association board chair Adam Rosenberg said Democratic control could help advance banking access, tax changes, and clearer rules for state-licensed businesses. He noted that the industry generates over $29 billion annually and supports over 400,000 workers.
Despite growing industry engagement, Republican congressional leaders have generally resisted legalization proposals. Political contributions from cannabis executives to Democratic fundraising groups have also drawn attention, alongside spending by a pro-Trump political committee supporting Republican lawmakers, including some who have opposed cannabis reform.
For firms like Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) that have for long participated in efforts to reform marijuana laws at state level, the excitement about Democratic control of Congress may be premature for the industry since Trump holds veto powers and any bill passed could be stopped in its tracks by opposition from the president.
About CNW420
CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of an article each business day at 4:20 p.m. Eastern – a tribute to the time synonymous with cannabis culture. The concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.
To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit https://www.CannabisNewsWire.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer
CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com
CannabisNewsWire is powered by IBN
